BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 23397592)

  • 1. First in vitro and in vivo results of an anti-human CD133-antibody coated coronary stent in the porcine model.
    Sedaghat A; Sinning JM; Paul K; Kirfel G; Nickenig G; Werner N
    Clin Res Cardiol; 2013 Jun; 102(6):413-25. PubMed ID: 23397592
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pro-Healing Nanomatrix-Coated Stent Analysis in an
    Zhang X; Chen J; Brott BC; Anderson PG; Hwang PTJ; Sherwood J; Huskin G; Yoon YS; Virmani R; Jun HW
    ACS Appl Mater Interfaces; 2022 Nov; 14(46):51728-51743. PubMed ID: 36346768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intraprocedural endothelial cell seeding of arterial stents via biotin/avidin targeting mitigates in-stent restenosis.
    Alferiev IS; Hooshdaran B; Pressly BB; Zoltick PW; Stachelek SJ; Chorny M; Levy RJ; Fishbein I
    Sci Rep; 2022 Nov; 12(1):19212. PubMed ID: 36357462
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting In-Stent-Stenosis with RGD- and CXCL1-Coated Mini-Stents in Mice.
    Simsekyilmaz S; Liehn EA; Weinandy S; Schreiber F; Megens RT; Theelen W; Smeets R; Jockenhövel S; Gries T; Möller M; Klee D; Weber C; Zernecke A
    PLoS One; 2016; 11(5):e0155829. PubMed ID: 27192172
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-CD34-Grafted Magnetic Nanoparticles Promote Endothelial Progenitor Cell Adhesion on an Iron Stent for Rapid Endothelialization.
    Chen J; Wang S; Wu Z; Wei Z; Zhang W; Li W
    ACS Omega; 2019 Nov; 4(21):19469-19477. PubMed ID: 31763571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The many roles of cathepsins in restenosis.
    Wang HL; Narisawa M; Wu P; Meng X; Cheng XW
    Heliyon; 2024 Feb; 10(3):e24720. PubMed ID: 38333869
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent advances to accelerate re-endothelialization for vascular stents.
    Bedair TM; ElNaggar MA; Joung YK; Han DK
    J Tissue Eng; 2017; 8():2041731417731546. PubMed ID: 28989698
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of a universal, oriented antibody immobilization method to functionalize vascular prostheses for enhanced endothelialization for potential clinical application.
    Zhang Q; Duncan S; Szulc DA; de Mestral C; Kutryk MJ
    J Biol Eng; 2023 Jun; 17(1):37. PubMed ID: 37264409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biofunctionalization of cardiovascular stents to induce endothelialization: Implications for in- stent thrombosis in diabetes.
    Marei I; Ahmetaj-Shala B; Triggle CR
    Front Pharmacol; 2022; 13():982185. PubMed ID: 36299902
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Restenosis after Coronary Stent Implantation: Cellular Mechanisms and Potential of Endothelial Progenitor Cells (A Short Guide for the Interventional Cardiologist).
    Gori T
    Cells; 2022 Jun; 11(13):. PubMed ID: 35805178
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endothelial Progenitor Cells in Coronary Artery Disease: From Bench to Bedside.
    Pelliccia F; Zimarino M; De Luca G; Viceconte N; Tanzilli G; De Caterina R
    Stem Cells Transl Med; 2022 May; 11(5):451-460. PubMed ID: 35365823
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Applying Principles of Regenerative Medicine to Vascular Stent Development.
    Selvakumar PP; Rafuse MS; Johnson R; Tan W
    Front Bioeng Biotechnol; 2022; 10():826807. PubMed ID: 35321023
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of stenting on coronary endothelium from a molecular biological view: Time for improvement?
    Cornelissen A; Vogt FJ
    J Cell Mol Med; 2019 Jan; 23(1):39-46. PubMed ID: 30353645
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distinctive effects of CD34- and CD133-specific antibody-coated stents on re-endothelialization and in-stent restenosis at the early phase of vascular injury.
    Wu X; Yin T; Tian J; Tang C; Huang J; Zhao Y; Zhang X; Deng X; Fan Y; Yu D; Wang G
    Regen Biomater; 2015 Jun; 2(2):87-96. PubMed ID: 26813006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stem cells: An eventual treatment option for heart diseases.
    Bilgimol JC; Ragupathi S; Vengadassalapathy L; Senthil NS; Selvakumar K; Ganesan M; Manjunath SR
    World J Stem Cells; 2015 Sep; 7(8):1118-26. PubMed ID: 26435771
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endothelial progenitor cells in cardiovascular diseases.
    Lee PS; Poh KK
    World J Stem Cells; 2014 Jul; 6(3):355-66. PubMed ID: 25126384
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro study of a novel nanogold-collagen composite to enhance the mesenchymal stem cell behavior for vascular regeneration.
    Hung HS; Chang CH; Chang CJ; Tang CM; Kao WC; Lin SZ; Hsieh HH; Chu MY; Sun WS; Hsu SH
    PLoS One; 2014; 9(8):e104019. PubMed ID: 25093502
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-CD133 antibody immobilized on the surface of stents enhances endothelialization.
    Li J; Li D; Gong F; Jiang S; Yu H; An Y
    Biomed Res Int; 2014; 2014():902782. PubMed ID: 24734251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characteristic of c-Kit+ progenitor cells in explanted human hearts.
    Matuszczak S; Czapla J; Jarosz-Biej M; Wiśniewska E; Cichoń T; Smolarczyk R; Kobusińska M; Gajda K; Wilczek P; Sliwka J; Zembala M; Zembala M; Szala S
    Clin Res Cardiol; 2014 Sep; 103(9):711-8. PubMed ID: 24722830
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.